Open Access Open Badges Short report

Efficient replication of pneumonia virus of mice (PVM) in a mouse macrophage cell line

Kimberly D Dyer1, Ingrid MM Schellens13, Cynthia A Bonville2, Brittany V Martin14, Joseph B Domachowske2 and Helene F Rosenberg15*

Author Affiliations

1 Laboratory of Allergic Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, USA

2 Department of Pediatrics, SUNY Upstate Medical University, Syracuse, New York, USA

3 Department of Immunology, University Medical Center Utrecht, Utrecht, The Netherlands

4 Department of Pharmacology, University of Colorado Health Sciences Center, Denver, Colorado, USA

5 Building 10, Room 11C215, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland 20892, USA

For all author emails, please log on.

Virology Journal 2007, 4:48  doi:10.1186/1743-422X-4-48

Published: 4 June 2007


Pneumonia virus of mice (PVM; family Paramyxoviridae, subfamily Pneumovirinae) is a natural respiratory pathogen of rodent species and an important new model for the study of severe viral bronchiolitis and pneumonia. However, despite high virus titers typically detected in infected mouse lung tissue in vivo, cell lines used routinely for virus propagation in vitro are not highly susceptible to PVM infection. We have evaluated several rodent and primate cell lines for susceptibility to PVM infection, and detected highest virus titers from infection of the mouse monocyte-macrophage RAW 264.7 cell line. Additionally, virus replication in RAW 264.7 cells induces the synthesis and secretion of proinflammatory cytokines relevant to respiratory virus disease, including tumor necrosis factor-α (TNF-α), interferon-β (IFN-β), macrophage inflammatory proteins 1α and 1β (MIP-1α and MIP-1β) and the functional homolog of human IL-8, mouse macrophage inflammatory peptide-2 (MIP-2). Identification and characterization of a rodent cell line that supports the replication of PVM and induces the synthesis of disease-related proinflammatory mediators will facilitate studies of molecular mechanisms of viral pathogenesis that will complement and expand on findings from mouse model systems.